Gynecologic and breast cancers with hereditary cancer predisposition syndromes
Approximately 20–25% of ovarian cancers, 5–10% of uterine cancers, and 5–10% of breast cancers are attributable to inherited pathogenic genetic alterations. Identifying characteristic germline mutations is crucial for patient management, as appropriate surveillance and further surgical interventions...
Saved in:
Main Authors: | Courtney F. Connelly, Sudarshana Roychoudhury, Yan Peng, Hua Guo, Roshni Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-11-01
|
Series: | Human Pathology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772736X24000367 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya
by: Eanas Saleh Elmaihub, et al.
Published: (2024-12-01) -
Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population
by: Dione Aguilar, et al.
Published: (2025-01-01) -
Prognostic factors in hereditary breast cancer: A review
by: Ziske Maritska, et al.
Published: (2024-08-01) -
Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported
by: Cesar Augusto B. Duarte, et al.
Published: (2024-08-01) -
Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer
by: Takuma Hayashi, et al.
Published: (2024-10-01)